US health panel loosens restrictions for controversial peptides popular online A US Food and Drug Administration (FDA) advisory panel has voted to loosen restrictions on controversial peptides that have become popular online, but have not been well researched for human usage
From Days 3 to 8, the medium was switched to Knockout DMEM, 20% Knockout Serum Replacer, beta-mercaptoethanol (BME, 100 M), 1% Glutamax, non-essential amino acids, and 1% DMSO
N., Brownfield, D
These findings may indicate an infection or other complication requiring medical evaluation
(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)
Retrieved 28 March 2007
